See also this year's filing and all EDGAR filings for this company.
PDF Report 0001618835_2022_Evofem_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001618835')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001618835, Evofem Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 30,140,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,774,000 |
| 3 | remainder_Assets | 6,598,000 |
| 4 | LiabilitiesCurrent | 137,663,000 |
| 5 | LiabilitiesNoncurrent | 4,424,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 4,055,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,709,000 |
| 9 | ResearchAndDevelopmentExpense | 33,129,000 |
| 10 | remainder_Expenses | 113,169,000 |
| 11 | remainder_Revenues | 8,244,000 |
| 12 | remainder_NetIncome | -38,374,000 |
| 13 | remainder_ComprehensiveNetIncome | 5,089,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,512,000 |
| 1 | Liabilities | 142,087,000 |
| 2 | Expenses | 175,062,000 |
| 3 | Revenues | 8,244,000 |
| 4 | StockholdersEquity | -99,575,000 |
| 5 | NetIncome | -205,192,000 |
| 6 | ComprehensiveNetIncome | -202,647,500 |
| 7 | BaseVar | 205,684,000 |
| 8 | EconomicCapitalRatio | -4.05 |
Edgar->Model Mapping
Feature Distribution
Change over Time
